SMLR vs. LQDA, KIDS, CATX, SIBN, IRMD, BVS, ZJYL, TMCI, NNOX, and AXGN
Should you be buying Semler Scientific stock or one of its competitors? The main competitors of Semler Scientific include Liquidia (LQDA), OrthoPediatrics (KIDS), Perspective Therapeutics (CATX), SI-BONE (SIBN), Iradimed (IRMD), Bioventus (BVS), Jin Medical International (ZJYL), Treace Medical Concepts (TMCI), Nano-X Imaging (NNOX), and AxoGen (AXGN). These companies are all part of the "medical equipment" industry.
Semler Scientific (NASDAQ:SMLR) and Liquidia (NASDAQ:LQDA) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their valuation, media sentiment, profitability, analyst recommendations, institutional ownership, earnings, dividends, risk and community ranking.
Semler Scientific has higher revenue and earnings than Liquidia. Liquidia is trading at a lower price-to-earnings ratio than Semler Scientific, indicating that it is currently the more affordable of the two stocks.
Liquidia has a consensus target price of $21.60, suggesting a potential upside of 86.37%. Given Liquidia's higher probable upside, analysts clearly believe Liquidia is more favorable than Semler Scientific.
Semler Scientific has a beta of 1.01, meaning that its stock price is 1% more volatile than the S&P 500. Comparatively, Liquidia has a beta of 0.32, meaning that its stock price is 68% less volatile than the S&P 500.
Liquidia received 187 more outperform votes than Semler Scientific when rated by MarketBeat users. Likewise, 66.67% of users gave Liquidia an outperform vote while only 50.00% of users gave Semler Scientific an outperform vote.
49.4% of Semler Scientific shares are held by institutional investors. Comparatively, 64.5% of Liquidia shares are held by institutional investors. 13.0% of Semler Scientific shares are held by company insiders. Comparatively, 31.6% of Liquidia shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
In the previous week, Liquidia had 5 more articles in the media than Semler Scientific. MarketBeat recorded 10 mentions for Liquidia and 5 mentions for Semler Scientific. Semler Scientific's average media sentiment score of 0.91 beat Liquidia's score of 0.78 indicating that Semler Scientific is being referred to more favorably in the media.
Semler Scientific has a net margin of 32.92% compared to Liquidia's net margin of -674.42%. Semler Scientific's return on equity of 30.36% beat Liquidia's return on equity.
Summary
Semler Scientific beats Liquidia on 11 of the 19 factors compared between the two stocks.
Get Semler Scientific News Delivered to You Automatically
Sign up to receive the latest news and ratings for SMLR and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding SMLR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Semler Scientific Competitors List
Related Companies and Tools
